Kairos Ventures logo

Kairos Ventures

North America, California, United States, Beverly Hills

Description

Kairos Ventures is a Beverly Hills, California-based venture capital firm established in 2014 by Jim Demetriades, specializing in the commercialization of scientific discoveries originating from leading research institutions and universities. The firm positions itself at the forefront of deep technology and hard science innovation, aiming to bridge the gap between groundbreaking academic research and market-ready solutions. Their investment thesis is centered on identifying and nurturing intellectual property and businesses with significant disruptive potential across various scientific domains, including life sciences, physical sciences, AI, robotics, and quantum computing.

The firm primarily invests at the seed and Series A stages, providing crucial early-stage capital to nascent companies. Kairos Ventures typically deploys initial checks ranging from $1 million to $10 million, demonstrating a commitment to substantial early support for its portfolio companies. This strategic focus allows them to engage deeply with scientific founders and assist in the complex process of translating laboratory breakthroughs into viable commercial products. To date, Kairos Ventures has invested in over 70 companies, showcasing a broad and active portfolio across its target sectors.

With a robust financial backing, Kairos Ventures has successfully raised over $1 billion in capital, underscoring its significant presence in the deep tech investment landscape. This substantial capital base enables the firm to provide follow-on funding and support its portfolio companies through various growth phases. For instance, their recent Kairos Ventures Fund IV, L.P. closed with $300 million in 2023, further solidifying their capacity for new investments and continued support. Their long-term partnership approach emphasizes not just capital infusion but also strategic guidance and access to a network of industry experts, aiming to accelerate the development and market adoption of complex scientific innovations.

Investor Profile

Kairos Ventures has backed more than 58 startups, with 1 new investments in the last 12 months alone. The firm has led 20 rounds, about 34% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $1M – $10M.

Stage Focus

  • Seed (38%)
  • Series A (33%)
  • Series Unknown (14%)
  • Series B (9%)
  • Series C (3%)
  • Series D (2%)
  • Debt Financing (2%)

Country Focus

  • United States (98%)
  • United Kingdom (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Manufacturing
  • Pharmaceutical
  • Medical Device
  • Chemical
  • Software
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kairos Ventures frequently co-invest with?

Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
BASF Venture Capital
Europe, Rheinland-Pfalz, Germany, Ludwigshafen
Co-Investments: 2
MBX Capital
North America, New York, United States, New York
Co-Investments: 2
Bison Ventures
North America, Washington, United States, Seattle
Co-Investments: 2
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Spruce Capital Partners
North America, California, United States, San Francisco
Co-Investments: 3
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 2
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 2
CV
North America, Connecticut, United States, Darien
Co-Investments: 3
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Kairos Ventures often collaborate with?

David R. Walt
North America, Massachusetts, United States, Boston
Shared Deals: 1
WL
North America, Texas, United States, Austin
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
HE
North America, Maryland, United States, Baltimore
Shared Deals: 1
JA
North America, Texas, United States, Austin
Shared Deals: 1
LS
North America, Florida, United States, Naples
Shared Deals: 1

What are some of recent deals done by Kairos Ventures?

Vivodyne

San Francisco, California, United States

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

BiotechnologyLifestyleMedical
Series AMay 29, 2025
Amount Raised: $40,000,000
Vivodyne

Philadelphia, Pennsylvania, United States

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

BiotechnologyLifestyleMedical
SeedNov 22, 2023
Amount Raised: $38,000,000
PteroDynamics

Colorado Springs, Colorado, United States

PteroDynamics is an aircraft design and manufacturing company that improve lives by democratizing transportation.

AerospaceMachinery ManufacturingManufacturing
SeedFeb 28, 2023
Amount Raised: $7,500,000
Behavioral Signals

Los Angeles, California, United States

Behavioral Signals develops technology to analyze human behavior from voice data.

AnalyticsArtificial Intelligence (AI)Machine LearningNatural Language ProcessingSpeech RecognitionVirtual Assistant
Series UnknownMar 30, 2022
TULU

New York, New York, United States

TULU is the Usage Economy platform that elevates products and services brands to win today’s needs-driven consumers.

CommunitiesProperty Management
SeedApr 13, 2021
Amount Raised: $3,000,000
Vivodyne

Philadelphia, Pennsylvania, United States

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

BiotechnologyLifestyleMedical
SeedMar 11, 2021
Amount Raised: $1,999,996
AetherTouch

Austin, Texas, United States

AetherTouch develops software that allows electronic users to control their devices without a single touch.

SoftwareTelecommunicationsWireless
SeedMar 3, 2021
Novosteo

Indiana, Pennsylvania, United States

Novosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall.

BiotechnologyHealth CarePharmaceutical
Series AJan 13, 2021
Amount Raised: $5,500,000
Provivi

Santa Monica, California, United States

Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.

AgricultureBiotechnologyChemical
Series CDec 22, 2020
Amount Raised: $45,500,000
Anycart

Palo Alto, California, United States

Anycart is the world's first grocery shopping engine.

E-CommerceFood and BeverageGroceryInternetMobile AppsShopping
SeedOct 8, 2020